Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
29.13
-0.59 (-1.99%)
At close: Mar 26, 2026

SHE:301108 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,3452,0702,8052,7424,886-
Market Cap Growth
49.83%-26.20%2.31%-43.89%--
Enterprise Value
2,2777822,0611,2204,583-
Last Close Price
29.7218.2824.1923.3140.75-
PE Ratio
77.82106.3624.3519.4522.21-
Forward PE
15.3214.3119.1915.76--
PS Ratio
4.753.784.514.114.96-
PB Ratio
1.781.131.511.542.89-
P/TBV Ratio
1.821.161.541.572.94-
P/FCF Ratio
---10.1938.30-
P/OCF Ratio
-27.5633.599.1724.41-
EV/Sales Ratio
3.231.433.311.834.66-
EV/EBITDA Ratio
19.6712.4915.347.2116.85-
EV/EBIT Ratio
37.9842.0020.089.0618.84-
EV/FCF Ratio
-9.76--4.5335.92-
Debt / Equity Ratio
0.020.010.010.020.020.11
Debt / EBITDA Ratio
0.290.130.130.190.150.22
Debt / FCF Ratio
---0.120.310.60
Net Debt / Equity Ratio
-0.57-0.81-0.71-0.72-0.81-0.61
Net Debt / EBITDA Ratio
-9.43-23.68-9.84-7.53-5.06-1.19
Net Debt / FCF Ratio
4.5870.26859.92-4.73-10.78-3.21
Asset Turnover
0.320.260.300.320.681.19
Inventory Turnover
6.086.146.654.475.486.96
Quick Ratio
4.697.696.266.125.451.27
Current Ratio
5.568.096.566.425.981.58
Return on Equity (ROE)
2.82%1.04%6.30%8.12%20.61%50.91%
Return on Assets (ROA)
1.71%0.55%3.04%4.09%10.45%21.01%
Return on Invested Capital (ROIC)
7.03%3.23%16.70%28.44%87.07%120.76%
Return on Capital Employed (ROCE)
3.10%1.00%5.40%7.40%13.80%44.30%
Earnings Yield
1.57%0.94%4.11%5.14%4.50%-
FCF Yield
-6.97%-1.02%-0.06%9.81%2.61%-
Dividend Yield
0.35%0.39%1.06%1.53%1.31%-
Payout Ratio
36.62%149.83%35.25%43.21%0.12%1.69%
Buyback Yield / Dilution
-55.65%0.01%-0.14%-29.59%-2.66%-0.12%
Total Shareholder Return
-55.28%0.40%0.92%-28.06%-1.34%-0.12%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.